Belle H de Rooij1, Nicole P M Ezendam2, Kim A H Nicolaije2, M Caroline Vos3, Johanna M A Pijnenborg3, Dorry Boll4, Erik A Boss5, Ralph H M Hermans5, Karin C M Engelhart6, Joke E Haartsen7, Brenda M Pijlman8, Ingrid E A M van Loon-Baelemans9, Helena J M M Mertens10, Willem E Nolting11, Johannes J van Beek12, Jan A Roukema13, Roy F P M Kruitwagen14, Lonneke V van de Poll-Franse15. 1. CoRPS - Center of Research on Psychology in Somatic diseases, Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands; The Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands. Electronic address: b.h.derooij@uvt.nl. 2. CoRPS - Center of Research on Psychology in Somatic diseases, Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands; The Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands. 3. Department of Gynecology, Elisabeth-TweeSteden Hospital, Tilburg, Waalwijk, The Netherlands. 4. Department of Gynecology, Catharina Hospital, Eindhoven, The Netherlands. 5. Department of Gynecology, Maxima Medical Center, Veldhoven and Eindhoven, The Netherlands. 6. Department of Gynecology, St. Anna Hospital, Geldrop, Eindhoven, The Netherlands. 7. Department of Gynecology, Elkerliek Hospital, Helmond, The Netherlands. 8. Department of Gynecology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands. 9. Department of Gynecology, Amphia Hospital, Breda, Oosterhout, The Netherlands. 10. Department of Gynecology, Zuyderland Medical Center, Sittard-Geleen, The Netherlands. 11. Department of Gynecology, St. Jans Hospital, Weert, The Netherlands. 12. Department of Gynecology, VieCuri Hospital, Venlo and Venray, The Netherlands. 13. CoRPS - Center of Research on Psychology in Somatic diseases, Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands; Department of Surgery, Elisabeth-Tweesteden Hospital, Tilburg, The Netherlands. 14. Department of Gynecology, and GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands. 15. CoRPS - Center of Research on Psychology in Somatic diseases, Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands; The Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Abstract
OBJECTIVE: The aim of this study was to assess the long-term impact of an automatically generated Survivorship Care Plan (SCP) on patient reported outcomes in ovarian cancer in routine clinical practice. Outcome measures included satisfaction with information provision and care, illness perceptions and health care utilization. METHODS: In this pragmatic cluster randomized trial, twelve hospitals in the South of the Netherlands were randomized to 'SCP care' or 'usual care'. All newly diagnosed ovarian cancer patients in the 'SCP care' arm received anSCP that was automatically generated by the oncology provider, by clicking a button in the web-based Registrationsystem Oncological GYnecology (ROGY). Ovarian cancer patients (N=174, mean age 63.3, SD=11.4; all stages) completed questionnaires directly after initial treatment and after 6, 12 and 24months. RESULTS: First questionnaires were returned from 61 (67%) ovarian cancer patients in the 'SCP care' arm and 113 (72%) patients in the 'usual care' arm. In the 'SCP care' arm, 66% (N=41) of the patients reported receipt of an SCP. No overall differences were observed between the trial arms on satisfaction with information provision, satisfaction with care or health care utilization. Regarding illness perceptions, patients in the 'SCP care' arm had lower beliefs that the treatment would help to cure their disease (overall, 6.7 vs. 7.5, P<0.01). CONCLUSIONS:SCPs did not increase satisfaction with information provision or care in ovarian cancer patients. Our trial results suggest that ovarian cancer patients may not benefit from an SCP. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01185626.
RCT Entities:
OBJECTIVE: The aim of this study was to assess the long-term impact of an automatically generated Survivorship Care Plan (SCP) on patient reported outcomes in ovarian cancer in routine clinical practice. Outcome measures included satisfaction with information provision and care, illness perceptions and health care utilization. METHODS: In this pragmatic cluster randomized trial, twelve hospitals in the South of the Netherlands were randomized to 'SCP care' or 'usual care'. All newly diagnosed ovarian cancerpatients in the 'SCP care' arm received an SCP that was automatically generated by the oncology provider, by clicking a button in the web-based Registrationsystem Oncological GYnecology (ROGY). Ovarian cancerpatients (N=174, mean age 63.3, SD=11.4; all stages) completed questionnaires directly after initial treatment and after 6, 12 and 24months. RESULTS: First questionnaires were returned from 61 (67%) ovarian cancerpatients in the 'SCP care' arm and 113 (72%) patients in the 'usual care' arm. In the 'SCP care' arm, 66% (N=41) of the patients reported receipt of an SCP. No overall differences were observed between the trial arms on satisfaction with information provision, satisfaction with care or health care utilization. Regarding illness perceptions, patients in the 'SCP care' arm had lower beliefs that the treatment would help to cure their disease (overall, 6.7 vs. 7.5, P<0.01). CONCLUSIONS: SCPs did not increase satisfaction with information provision or care in ovarian cancerpatients. Our trial results suggest that ovarian cancerpatients may not benefit from an SCP. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01185626.
Authors: Sarah A Birken; Alecia S Clary; Shampa Bernstein; Jamiyla Bolton; Miriam Tardif-Douglin; Deborah K Mayer; Allison M Deal; Sara R Jacobs Journal: J Oncol Pract Date: 2018-07-13 Impact factor: 3.840
Authors: Sarah A Birken; Sarah Raskin; Yuqing Zhang; Gema Lane; Alexandra Zizzi; Mandi Pratt-Chapman Journal: J Cancer Educ Date: 2019-06 Impact factor: 2.037
Authors: Sarah A Birken; Robin Urquhart; Corrine Munoz-Plaza; Alexandra R Zizzi; Emily Haines; Angela Stover; Deborah K Mayer; Erin E Hahn Journal: J Cancer Surviv Date: 2018-03-23 Impact factor: 4.442
Authors: Rebecca E Hill; Claire E Wakefield; Richard J Cohn; Joanna E Fardell; Mary-Ellen E Brierley; Emily Kothe; Paul B Jacobsen; Kate Hetherington; Rebecca Mercieca-Bebber Journal: Oncologist Date: 2019-10-25
Authors: Rebecca E Hill; Claire E Wakefield; Richard J Cohn; Joanna E Fardell; Mary-Ellen E Brierley; Emily Kothe; Paul B Jacobsen; Kate Hetherington; Rebecca Mercieca-Bebber Journal: Oncologist Date: 2019-10-25
Authors: Bradley D McDowell; Jennifer Klemp; Anne Blaes; Andrea A Cohee; Amy Trentham-Dietz; Sailaja Kamaraju; Julie L Otte; Sarah L Mott; Elizabeth A Chrischilles Journal: Support Care Cancer Date: 2019-06-05 Impact factor: 3.603
Authors: Amye J Tevaarwerk; William G Hocking; Kevin A Buhr; Mindy Gribble; Lori A Seaborne; Kari B Wisinski; Mark E Burkard; Thomas Yen; Douglas A Wiegmann; Mary E Sesto Journal: Cancer Date: 2019-01-28 Impact factor: 6.860
Authors: Amye J Tevaarwerk; Jennifer R Klemp; Gijsberta J van Londen; Bradford W Hesse; Mary E Sesto Journal: Cancer Date: 2018-09-12 Impact factor: 6.860